Blau wants to quadruple capacity Pharmaceutical

Even without the funds from the initial offering of shares (IPO), which was not to the front at the beginning of the year, the Blau plans to expand in four Pharmaceutical times your production capacity over a period of three years. For 2018, the projection is of the order of 18% growth in your billing. Even with this expansion, the company wants to keep your niche, which are medical hospitals. The Blau, who also owns the brand of condom Preserv, reinforced box in R $180 million with the launch of debentures in July. The roles were encarteirados by Bradesco, which was not among the banks coordinators during the attempted IPO. "Consulting". After the roadshows with investors earlier this year, still under the IPO, the Blau received feedback that there was a market concern about the dependence of the company in relation to contracts with the public sector. However, this year, the share of private sector sales grew to 54%. One of the bottlenecks for further expansion by the private sector, was exactly the lack of production capacity, which is already being addressed by the company. After the increase, the company should aim also to international expansion and markets focus is Asia. In Latin America, she is already present in countries such as Chile, Colombia, Peru, Uruguay and Argentina, among others. In the future, an IPO should be back at the table, as soon as the market appears "favourable".